A 69-year-old white woman developed cystoid macular edema (CME) 16 days after cataract surgery (Irvine-Gass syndrome). Surgery included phacoemulsification with a small-incision technique, stop-and-chop, and implantation of an intraocular lens in the right eye. No complications occurred during surgery, and the standard treatment of tobramycin 0.3%-dexamethasone 0.1% and diclofenac was started postoperatively. Spectral-domain optical coherence tomography showed a central retinal thickness of 857 μm. Bromfenac 0.9 mg/mL was initiated, and the symptoms improved after 5 days. Approximately a month after the initiation of bromfenac, the CME resolved with a reduction of central retinal thickness to 203 μm. Bromfenac eyedrops have proven to be an effective and noninvasive treatment option in Irvine-Gass syndrome. © ASCRS and ESCRS.
Irvine-Gass syndrome after cataract surgery resolved by topical therapy with bromfenac eyedrops
Di Staso, S.
2014-01-01
Abstract
A 69-year-old white woman developed cystoid macular edema (CME) 16 days after cataract surgery (Irvine-Gass syndrome). Surgery included phacoemulsification with a small-incision technique, stop-and-chop, and implantation of an intraocular lens in the right eye. No complications occurred during surgery, and the standard treatment of tobramycin 0.3%-dexamethasone 0.1% and diclofenac was started postoperatively. Spectral-domain optical coherence tomography showed a central retinal thickness of 857 μm. Bromfenac 0.9 mg/mL was initiated, and the symptoms improved after 5 days. Approximately a month after the initiation of bromfenac, the CME resolved with a reduction of central retinal thickness to 203 μm. Bromfenac eyedrops have proven to be an effective and noninvasive treatment option in Irvine-Gass syndrome. © ASCRS and ESCRS.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
